OTC Markets OTCPK - Delayed Quote USD

Novonesis A/S (NVZMY)

Compare
67.12 -1.16 (-1.70%)
At close: 9:32 AM EDT
Loading Chart for NVZMY
DELL
  • Previous Close 68.28
  • Open 67.19
  • Bid 66.88 x 40000
  • Ask 66.99 x 40000
  • Day's Range 67.12 - 67.19
  • 52 Week Range 38.83 - 72.50
  • Volume 300
  • Avg. Volume 9,817
  • Market Cap (intraday) 31.343B
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) 65.80
  • EPS (TTM) 1.02
  • Earnings Date Oct 24, 2024 - Oct 28, 2024
  • Forward Dividend & Yield 0.58 (0.86%)
  • Ex-Dividend Date Sep 9, 2024
  • 1y Target Est 75.50

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

www.novonesis.com

10,452

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NVZMY

View More

Performance Overview: NVZMY

Trailing total returns as of 10/16/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NVZMY
23.42%
OMX Copenhagen 25 Index
5.66%

1-Year Return

NVZMY
66.68%
OMX Copenhagen 25 Index
13.25%

3-Year Return

NVZMY
1.03%
OMX Copenhagen 25 Index
1.35%

5-Year Return

NVZMY
62.97%
OMX Copenhagen 25 Index
68.82%

Compare To: NVZMY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NVZMY

View More

Valuation Measures

Annual
As of 10/15/2024
  • Market Cap

    31.81B

  • Enterprise Value

    33.70B

  • Trailing P/E

    66.97

  • Forward P/E

    27.86

  • PEG Ratio (5yr expected)

    0.24

  • Price/Sales (ttm)

    7.49

  • Price/Book (mrq)

    2.63

  • Enterprise Value/Revenue

    10.13

  • Enterprise Value/EBITDA

    65.05

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.29%

  • Return on Assets (ttm)

    3.45%

  • Return on Equity (ttm)

    4.38%

  • Revenue (ttm)

    3.04B

  • Net Income Avi to Common (ttm)

    282.79M

  • Diluted EPS (ttm)

    1.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    260.8M

  • Total Debt/Equity (mrq)

    18.08%

  • Levered Free Cash Flow (ttm)

    21.34M

Research Analysis: NVZMY

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 915.85M
Earnings 31.95M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

71.00
75.50 Average
67.12 Current
80.00 High
 

Company Insights: NVZMY

People Also Watch